Zoetis (ZTS) Change in Receivables (2014 - 2026)
Zoetis' (ZTS) quarterly Change in Receivables came in at $66.0 million in Q2 2026, down 37.74% year-over-year from $106.0 million in Q2 2025, and down 37.74% quarter-over-quarter from $106.0 million in Q1 2026.
Analysis
Zoetis (ZTS) Change in Receivables (2014 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Change in Receivables for 13 consecutive years, with $66.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Receivables fell 37.74% year-over-year to $66.0 million in Q2 2026; TTM through Jun 2026 was $256.0 million, a 153.47% increase from a year earlier, with the FY2025 full-year figure at $236.0 million, up 286.89% from the prior year.
- Change in Receivables was $66.0 million for Q2 2026 at Zoetis, down from $106.0 million in the prior quarter.
- Over five years, Change in Receivables peaked at $143.0 million in Q2 2023 and troughed at -$73.0 million in Q4 2024.
- A 5-year average of $39.3 million and a median of $47.0 million in 2023 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables plunged 933.33% in 2022 and jumped 283.33% in 2025, its largest moves.
- Over 5 years, Change in Receivables stood at $17.0 million in 2022, then jumped by 182.35% to $48.0 million in 2023, then sank by 252.08% to -$73.0 million in 2024, then surged by 171.23% to $52.0 million in 2025, then grew by 26.92% to $66.0 million in 2026.
- The last three Change in Receivables figures came in at $66.0 million (Q2 2026), $106.0 million (Q1 2026), and $52.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.69 Bn | 40.49 Bn | 779.09 Mn | 26.04 Mn |
| 2 | Zoetis | 30.63 Bn | 28.95 Bn | 1.05 Bn | 66.00 Mn |
| 3 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | - |
| 4 | Phibro Animal Health | 1.49 Bn | 1.41 Bn | 134.40 Mn | 16.42 Mn |
| 5 | Immucell | 90.19 Mn | 81.33 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 76.23 Mn | 69.14 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -3,300.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 66.00 Mn |
| Mar 31, 2026 | 106.00 Mn |
| Dec 31, 2025 | 52.00 Mn |
| Sep 30, 2025 | 32.00 Mn |
| Jun 30, 2025 | 106.00 Mn |
| Mar 31, 2025 | 46.00 Mn |
| Dec 31, 2024 | -73.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | 100.00 Mn |
| Mar 31, 2024 | 12.00 Mn |
| Dec 31, 2023 | 48.00 Mn |
| Sep 30, 2023 | -62.00 Mn |
| Jun 30, 2023 | 143.00 Mn |
| Mar 31, 2023 | -27.00 Mn |
| Dec 31, 2022 | 17.00 Mn |
| Sep 30, 2022 | -62.00 Mn |
| Jun 30, 2022 | 80.00 Mn |
| Mar 31, 2022 | 102.00 Mn |
| Dec 31, 2021 | 12.00 Mn |
| Sep 30, 2021 | -6.00 Mn |